| 000 | 01074 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250511211557.0 | ||
| 264 | 0 | _c19911004 | |
| 008 | 199110s 0 0 eng d | ||
| 022 | _a0031-6970 | ||
| 024 | 7 |
_a10.1007/BF00279967 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVeronese, M E | |
| 245 | 0 | 0 |
_aMetabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _c1991 |
||
| 300 |
_a547-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAcetaminophen _xmetabolism |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aDebrisoquin _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPhenacetin _xmetabolism |
| 650 | 0 | 4 | _aPhenotype |
| 700 | 1 | _aMcLean, S | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 40 _gno. 6 _gp. 547-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00279967 _zAvailable from publisher's website |
| 999 |
_c1890938 _d1890938 |
||